Tags

Type your tag names separated by a space and hit enter

Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
Clin Ther. 1986; 8(2):219-25.CT

Abstract

Oral potassium citrate therapy was recently approved for treatment of urolithiasis based on results of experiments in a university research setting. However, no supporting studies from private practice have been published. The present study was undertaken to assess the response to one week of oral potassium citrate therapy (60 mEq/day), with respect to urinary risk factors for kidney stones, in a private practice setting. A significant rise in urinary pH, citrate, and potassium excretion, accompanying a significant fall in calcium excretion, were observed. Urinary saturation of calcium oxalate was significantly reduced, as some risk factors in urolithiasis were corrected with oral potassium citrate therapy. The response to therapy in private practice was comparable to that observed in a university research setting.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

3698069

Citation

Nicar, M J., et al. "Urinary Response to Oral Potassium Citrate Therapy for Urolithiasis in a Private Practice Setting." Clinical Therapeutics, vol. 8, no. 2, 1986, pp. 219-25.
Nicar MJ, Hsu MC, Fetner C. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. Clin Ther. 1986;8(2):219-25.
Nicar, M. J., Hsu, M. C., & Fetner, C. (1986). Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. Clinical Therapeutics, 8(2), 219-25.
Nicar MJ, Hsu MC, Fetner C. Urinary Response to Oral Potassium Citrate Therapy for Urolithiasis in a Private Practice Setting. Clin Ther. 1986;8(2):219-25. PubMed PMID: 3698069.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. AU - Nicar,M J, AU - Hsu,M C, AU - Fetner,C, PY - 1986/1/1/pubmed PY - 1986/1/1/medline PY - 1986/1/1/entrez SP - 219 EP - 25 JF - Clinical therapeutics JO - Clin Ther VL - 8 IS - 2 N2 - Oral potassium citrate therapy was recently approved for treatment of urolithiasis based on results of experiments in a university research setting. However, no supporting studies from private practice have been published. The present study was undertaken to assess the response to one week of oral potassium citrate therapy (60 mEq/day), with respect to urinary risk factors for kidney stones, in a private practice setting. A significant rise in urinary pH, citrate, and potassium excretion, accompanying a significant fall in calcium excretion, were observed. Urinary saturation of calcium oxalate was significantly reduced, as some risk factors in urolithiasis were corrected with oral potassium citrate therapy. The response to therapy in private practice was comparable to that observed in a university research setting. SN - 0149-2918 UR - https://www.unboundmedicine.com/medline/citation/3698069/Urinary_response_to_oral_potassium_citrate_therapy_for_urolithiasis_in_a_private_practice_setting_ DB - PRIME DP - Unbound Medicine ER -